Learn More
Log In
Sign Up
Additional Safeguards for Children in Clinical Investigations | Midpage
Collections
Code of Federal Regulations
Title 21
Chapter I
Subchapter A
Part 50
Subpart D
Additional Safeguards for Children in Clinical Investigations
50.50
IRB duties.
50.51
Clinical investigations not involving greater than minimal risk.
50.52
Clinical investigations involving greater than minimal risk but presenting the prospect of direct benefit to individual subjects.
50.53
Clinical investigations involving greater than minimal risk and no prospect of direct benefit to individual subjects, but likely to yield generalizable knowledge about the subjects' disorder or condition.
50.54
Clinical investigations not otherwise approvable that present an opportunity to understand, prevent, or alleviate a serious problem affecting the health or welfare of children.
50.55
Requirements for permission by parents or guardians and for assent by children.
50.56
Wards.